Search Results - Piotr Czaykowski
- Showing 1 - 9 results of 9
-
1
-
2
Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: a Canadian Urologic Oncology Group/German Testicular Can... by Karin Oechsle, Friedemann Honecker, Tina Cheng, Frank Mayer, Piotr Czaykowski, Eric Winquist, Lori Wood, Martin Fenner, Stephanie Glaesener, J.T. Hartmann, K.N. Chi, Carsten Bokemeyer, Christian Kollmannsberger
Published 2011Artigo -
3
Phase III Trial of Bevacizumab Plus Interferon Alfa Versus Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: Final Results of CALGB 90206 by Brian I. Rini, Susan Halabi, Jonathan E. Rosenberg, Walter M. Stadler, Daniel A. Vaena, Laura Archer, James N. Atkins, Joel Picus, Piotr Czaykowski, Janice P. Dutcher, Eric J. Small
Published 2010Carta -
4
A phase II study of sorafenib in patients with chemo-naive castration-resistant prostate cancer by K.N. Chi, Susan Ellard, Sébastien J. Hotte, Piotr Czaykowski, Malcolm J. Moore, Joseph D. Ruether, Andrew Schell, Sarah Taylor, Charlotte Toftmann Hansen, L. Gauthier, William R. Walsh, Lesley Seymour
Published 2007Artigo -
5
Randomized Phase II Trial of Custirsen (OGX-011) in Combination with Docetaxel or Mitoxantrone as Second-line Therapy in Patients with Metastatic Castrate-Resistant Prostate Cancer... by Fred Saad, Sébastien J. Hotte, Scott North, Bernhard J. Eigl, Kim Chi, Piotr Czaykowski, Lori Wood, Michaël Pollak, Scott Berry, Jean‐Baptiste Lattouf, Som D. Mukherjee, Martin Gleave, Eric Winquist
Published 2011Artigo -
6
Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 90206 by Brian I. Rini, Susan Halabi, Jonathan E. Rosenberg, Walter M. Stadler, Daniel A. Vaena, San-San Ou, Laura Archer, James N. Atkins, Joel Picus, Piotr Czaykowski, Janice P. Dutcher, Eric J. Small
Published 2008Artigo -
7
Canadian Consensus Recommendations on the Management of Venous Thromboembolism in Patients with Cancer. Part 1: Prophylaxis by Jacob C. Easaw, Melissa Shea‐Budgell, Chengliang Wu, Piotr Czaykowski, Jeannine Kassis, B.L. KUEHL, Howard J. Lim, Mary MacNeil, Daniel J Martinusen, Phil McFarlane, Ed Meek, Otto Moodley, Sudeep Shivakumar, Vicky Tagalakis, S. Welch, Petr Kavan
Published 2015Artigo -
8
Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 2: treatment by Jacob C. Easaw, Melissa Shea‐Budgell, Chengliang Wu, Piotr Czaykowski, Jeannine Kassis, B.L. KUEHL, Hee-Yong Lim, Mary MacNeil, Dan Martinusen, P A McFarlane, Ed Meek, Otto Moodley, Sudeep Shivakumar, Vicky Tagalakis, S. Welch, Petr Kavan
Published 2015Artigo -
9
Management of Germ Cell Tumors During the Outbreak of the Novel Coronavirus Disease-19 Pandemic: A Survey of International Expertise Centers by Lucia Nappi, Margaret Ottaviano, Pasquale Rescigno, Marianna Tortora, Giuseppe Luigi Banna, Giulia Baciarello, Umberto Basso, Christina Canil, Alessia Cavo, Maria Cossu Rocca, Piotr Czaykowski, Ugo De Giorgi, Xavier García del Muro, Marilena Di Napoli, Giuseppe Fornarini, Jourik A. Gietema, Daniel Yick Chin Heng, Sébastien J. Hotte, Christian Kollmannsberger, Marco Maruzzo, Carlo Messina, Franco Morelli, Sasja F. Mulder, Craig R. Nichols, Franco Nolè, Christoph Oing, Teodoro Sava, Simona Secondino, Giuseppe Simone, Denis Soulières, Bruno Vincenzi, Paolo Andrea Zucali, Sabino De Placido, Giovannella Palmieri
Published 2020Artigo
Search Tools:
Related Subjects
Internal medicine
Medicine
Cancer
Chemotherapy
Oncology
Gastroenterology
Pathology
Clinical endpoint
Clinical trial
Disease
Surgery
Urology
Bevacizumab
Confidence interval
Coronavirus disease 2019 (COVID-19)
Germ cell tumors
Guideline
Hazard ratio
Infectious disease (medical specialty)
Intensive care medicine
Low molecular weight heparin
Pandemic
Prostate cancer
Randomized controlled trial
Renal cell carcinoma
Thrombosis
Venous thromboembolism
2019-20 coronavirus outbreak
Adverse effect
Alpha interferon